P937: PRECLINICAL DISCOVERY AND EARLY FINDINGS FROM THE PHASE 1, DOSE-ESCALATION STUDY OF WVT078, A BCMA-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH R/R MULTIPLE MYELOMA di M. S. Raab, Y. C. Cohen, F. Schjesvold, K. Aardalen, A. Oka, A. Spencer, M. Wermke, P. Hari, J. L. Kaufman, A. M. Cafro, E. M. Ocio, N. Doki, K. Henson, G. Trabucco, P.-E. Juif, R. Chawla, J. Cotton, A. Fessehatsion, L. Fan, J. Blankenship, B. Granda, H. Lu, S. De Vita

Testo